Transgenics Added To Brazil Patent Law

18 June 1995

Brazil's Chancellor, Luis Felipe Lampreira, has added an extra clause to the country's proposed new patent legislation, providing for the one-time patenting of transgenic micro-organisms. This is not covered by the agreement on Trade Related Aspects of Intellectual Property Rights.

However, the Chancellor commented that nobody can guarantee when the new law would be approved, and this is a problem, he said. During April, the Senate's Constitutional and Justice Commission twice postponed a vote on the legislation, even though the country's President, Fernando Henrique Cardoso, assured US President Bill Clinton, during a visit to the USA, that the passage of an intellectual property law that would satisfy US requirements was close.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight